TRiP

TRiP provides comprehensive RNAi and CRISPR reagent collections for targeted loss- and gain-of-function functional genomics studies in Drosophila.

Key Features:

• RNAi stock collection: Over 15,000 RNAi fly stocks covering the majority of genes in the Drosophila genome for loss-of-function studies.
• CRISPR integration: CRISPR-based collections expanded the resource to include both overexpression and knockout reagents.
• TRiP-OE (overexpression): Uses single guide RNAs (sgRNAs) targeting regions upstream of a gene's transcription start site to enable transcriptional activation.
• Activation domains: Activation in TRiP-OE is achieved by co-expression of catalytically inactive Cas9 (dCas9) fused to VP64-p65-Rta (VPR) or the Synergistic Activation Mediator (SAM) activator complexes.
• TRiP-KO (knockout): Uses one or two sgRNAs targeting coding sequence to induce insertions or deletions (indels) for loss-of-function alleles.
• Tissue targeting: TRiP-KO induces indels in both germline and somatic tissues.
• CRISPR stock scale: The project has generated over 5,000 CRISPR-OE and CRISPR-KO fly stocks.

Scientific Applications:

• Loss-of-function analysis: Systematic gene knockdown and knockout studies to assess gene function in Drosophila.
• Gain-of-function analysis: Transcriptional activation studies to evaluate phenotypes from gene overexpression.
• Functional genomics: Large-scale screens and targeted experiments to map gene function across the Drosophila genome.
• Allele generation: Creation of indel-containing knockout alleles in germline and somatic tissues for genetic studies.
• Genetic engineering: Use of dCas9-VPR/SAM and sgRNA targeting strategies for precise perturbation of gene expression.

Methodology:

No computational methods were specified in the input.